HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Danfang Zhang Selected Research

cadherin 5

1/2019S1PR1 regulates the switch of two angiogenic modes by VE-cadherin phosphorylation in breast cancer.
1/2017Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry.
8/2016Notch4+ cancer stem-like cells promote the metastatic and invasive ability of melanoma.
1/2016Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype.
4/2015Subpopulations of uPAR+ contribute to vasculogenic mimicry and metastasis in large cell lung cancer.
9/2007Vasculogenic mimicry: current status and future prospects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Danfang Zhang Research Topics

Disease

31Neoplasms (Cancer)
10/2022 - 01/2006
12Breast Neoplasms (Breast Cancer)
12/2021 - 12/2006
11Neoplasm Metastasis (Metastasis)
10/2022 - 11/2008
9Melanoma (Melanoma, Malignant)
08/2020 - 01/2006
9Hypoxia (Hypoxemia)
01/2018 - 05/2007
5Hepatocellular Carcinoma (Hepatoma)
10/2022 - 12/2014
4Experimental Melanoma
05/2009 - 01/2006
3Triple Negative Breast Neoplasms
09/2014 - 11/2008
2Lymphatic Metastasis
10/2022 - 12/2006
2Carcinoma (Carcinomatosis)
01/2017 - 08/2015
1Wounds and Injuries (Trauma)
12/2021
1Adenoma (Adenomas)
08/2015
1Colorectal Neoplasms (Colorectal Cancer)
08/2015
1Lung Neoplasms (Lung Cancer)
04/2015
1Anemia
10/2014
1Hepatomegaly
12/2009
1Splenomegaly
12/2009
1Pathologic Neovascularization
11/2009
1Necrosis
05/2009
1Prostatic Neoplasms (Prostate Cancer)
11/2008

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
10/2022 - 05/2007
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 10/2006
6cadherin 5IBA
01/2019 - 09/2007
5Messenger RNA (mRNA)IBA
01/2021 - 11/2007
4Small Interfering RNA (siRNA)IBA
08/2020 - 09/2014
4Matrix Metalloproteinases (MMPs)IBA
12/2017 - 10/2006
4Sunitinib (Sutent)FDA Link
01/2017 - 11/2009
4VimentinIBA
08/2016 - 11/2008
3CateninsIBA
01/2017 - 08/2015
3Angiogenesis InhibitorsIBA
01/2017 - 03/2011
3Biological ProductsIBA
01/2017 - 12/2009
3Cadherins (E-Cadherin)IBA
08/2016 - 04/2015
3Oxygen (Dioxygen)IBA
09/2014 - 01/2006
3ClusterinIBA
03/2012 - 12/2006
3ParaffinIBA
12/2006 - 01/2006
2Long Noncoding RNAIBA
10/2022 - 10/2018
2Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2008
2Transcription Factors (Transcription Factor)IBA
01/2017 - 09/2014
2Doxycycline (Periostat)FDA LinkGeneric
12/2014 - 11/2007
2Progesterone Receptors (Progesterone Receptor)IBA
03/2012 - 11/2008
2Estrogen ReceptorsIBA
03/2012 - 11/2008
2SuspensionsIBA
11/2007 - 01/2006
1MicroRNAs (MicroRNA)IBA
10/2022
1Cell Adhesion MoleculesIBA
12/2021
1Eukaryotic Initiation Factor-4EIBA
12/2021
1Peptide Initiation Factors (Initiation Factor)IBA
12/2021
1LigandsIBA
08/2020
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
08/2020
1Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
01/2019
1Sphingosine-1-Phosphate ReceptorsIBA
01/2019
1Nuclear Proteins (Protein, Nuclear)IBA
01/2018
1Sirolimus (Rapamycin)FDA Link
12/2017
1Mechanistic Target of Rapamycin Complex 2IBA
12/2017
1SialomucinsIBA
01/2017
14- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA
10/2016
1Epidermal Growth Factor (EGF)IBA
08/2016
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
08/2016
1CaspasesIBA
01/2016
1NestinIBA
01/2016
1CalciumIBA
01/2016
1Matrix Metalloproteinase 13IBA
04/2015
1KalininIBA
04/2015
1Urokinase Plasminogen Activator ReceptorsIBA
04/2015
1Estrogens (Estrogen)FDA Link
03/2012
1human ERBB2 proteinIBA
03/2012
1Cytostatic AgentsIBA
03/2011
1Pharmaceutical PreparationsIBA
03/2011
1Hormones (Hormone)IBA
12/2009
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2009
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
11/2009
1MorpholinosIBA
11/2009
1Deoxyribonucleases (DNase)FDA Link
05/2009
1AntibodiesIBA
04/2009
1CXCR4 Receptors (CXCR4 Receptor)IBA
11/2008
1plerixaforFDA Link
11/2008
1Chemokine CXCL12IBA
11/2008
1moesinIBA
11/2008
1TubulinIBA
11/2008
1Saline SolutionIBA
11/2007
1GelatinIBA
11/2007
1Metalloproteases (Metalloproteinases)IBA
09/2007
1Laminin (Merosin)IBA
09/2007
1Formaldehyde (Formol)FDA Link
12/2006
1EndoglinIBA
10/2006
1CarbonIBA
01/2006
1Periodic AcidIBA
01/2006
1Platelet Endothelial Cell Adhesion Molecule-1IBA
01/2006

Therapy/Procedure

8Therapeutics
08/2020 - 11/2009
2Drug Therapy (Chemotherapy)
03/2011 - 12/2006
1Replantation
12/2021
1Injections
04/2009
1Lasers (Laser)
07/2007